Protective role of chaperone-mediated autophagy against atherosclerosis

Julio Madrigal-Matute1,2, Jenny de Bruijn3, Kim van Kuijk3,4

  • 1Department of Development and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY 10461.

Insights

Reduced chaperone-mediated autophagy (CMA) activity worsens atherosclerosis by affecting vascular smooth muscle cells and macrophages. Boosting CMA may offer a new therapeutic strategy for cardiovascular diseases.

Area of Science:

  • Cellular biology
  • Metabolic regulation
  • Cardiovascular research

Background:

  • Chaperone-mediated autophagy (CMA) regulates energy homeostasis through enzyme degradation.
  • CMA's role in atherosclerosis, particularly in vascular cells and macrophages, is not fully understood.

Purpose of the Study:

  • To investigate the role of CMA in the pathogenesis of atherosclerosis.
  • To determine if CMA modulation affects atherosclerotic plaque development and cellular behavior.

Main Methods:

  • Assessing CMA activity in murine and human arteries under atherosclerotic conditions.
  • Utilizing genetic models with blocked or upregulated CMA in vivo.
  • Analyzing changes in vascular smooth muscle cells and macrophages in response to CMA manipulation.

Main Results:

  • CMA activity is reduced in vascular smooth muscle cells and macrophages during atherosclerosis.
  • Genetic blockage of CMA exacerbates atherosclerotic pathology and promotes vascular smooth muscle cell dedifferentiation and macrophage inflammation.
  • Upregulated CMA reduces susceptibility to proatherosclerotic challenges.

Conclusions:

  • CMA plays a critical protective role in preventing atherosclerosis.
  • CMA deficiency promotes key cellular changes that drive atherogenesis.
  • CMA represents a potential therapeutic target for cardiovascular diseases.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.7K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.0K
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
18.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
54
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
137
Inflammation01:38

Inflammation

Overview
55.8K